Sept 1 (Reuters) - Argenica Therapeutics Ltd AGN.AX:
SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PHASE 2 ARG-007 STROKE TRIAL RESULTS
Further company coverage: AGN.AX
((Reuters.Briefs@thomsonreuters.com;))
Sept 1 (Reuters) - Argenica Therapeutics Ltd AGN.AX:
SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PHASE 2 ARG-007 STROKE TRIAL RESULTS
Further company coverage: AGN.AX
((Reuters.Briefs@thomsonreuters.com;))
Comments